WESTON, Fla., May 1, 2019 /PRNewswire/ -- Variant Pharmaceuticals, Inc., a clinical stage specialty biopharmaceutical company developing first-in-class drugs for patients with high unmet medical needs, is pleased to announce that we have changed our name to ZyVersa Therapeutics effective...
from PR Newswire: https://prn.to/2GV4kgD
No comments:
Post a Comment